Vanguard Group’s Pulse Biosciences PLSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $15.4M | Buy |
1,118,743
+5,052
| +0.5% | +$78.7K | ﹤0.01% | 2743 |
|
|
2025
Q3 | $19.7M | Sell |
1,113,691
-110,056
| -9% | -$1.74M | ﹤0.01% | 2636 |
|
|
2025
Q2 | $18.5M | Buy |
1,223,747
+380,693
| +45% | +$6.32M | ﹤0.01% | 2595 |
|
|
2025
Q1 | $13.6M | Sell |
843,054
-303,285
| -26% | -$5.65M | ﹤0.01% | 2682 |
|
|
2024
Q4 | $20M | Buy |
1,146,339
+150,506
| +15% | +$2.65M | ﹤0.01% | 2585 |
|
|
2024
Q3 | $17.5M | Buy |
995,833
+90,446
| +10% | +$1.54M | ﹤0.01% | 2654 |
|
|
2024
Q2 | $10.1M | Buy |
905,387
+58,175
| +7% | +$548K | ﹤0.01% | 2910 |
|
|
2024
Q1 | $7.38M | Buy |
847,212
+189,227
| +29% | +$1.74M | ﹤0.01% | 3128 |
|
|
2023
Q4 | $8.05M | Buy |
657,985
+316,519
| +93% | +$2.19M | ﹤0.01% | 3071 |
|
|
2023
Q3 | $1.38M | Buy |
341,466
+51,386
| +18% | +$319K | ﹤0.01% | 3725 |
|
|
2023
Q2 | $2.09M | Sell |
290,080
-278,555
| -49% | -$1.78M | ﹤0.01% | 3639 |
|
|
2023
Q1 | $1.91M | Buy |
568,635
+3,861
| +0.7% | +$11.6K | ﹤0.01% | 3693 |
|
|
2022
Q4 | $1.56M | Buy |
564,774
+301
| +0.1% | +$676 | ﹤0.01% | 3756 |
|
|
2022
Q3 | $1.3M | Sell |
564,473
-24,291
| -4% | -$39.4K | ﹤0.01% | 3916 |
|
|
2022
Q2 | $901K | Sell |
588,764
-72,655
| -11% | -$183K | ﹤0.01% | 4122 |
|
|
2022
Q1 | $3.21M | Sell |
661,419
-3,623
| -0.5% | -$29.7K | ﹤0.01% | 3745 |
|
|
2021
Q4 | $9.85M | Sell |
665,042
-44,813
| -6% | -$892K | ﹤0.01% | 3213 |
|
|
2021
Q3 | $15.3M | Buy |
709,855
+6,407
| +0.9% | +$138K | ﹤0.01% | 2999 |
|
|
2021
Q2 | $11.5M | Buy |
703,448
+47,306
| +7% | +$900K | ﹤0.01% | 3128 |
|
|
2021
Q1 | $15.5M | Buy |
656,142
+16,988
| +3% | +$508K | ﹤0.01% | 2925 |
|
|
2020
Q4 | $15.3M | Sell |
639,154
-699
| -0.1% | -$11.1K | ﹤0.01% | 2772 |
|
|
2020
Q3 | $7.54M | Sell |
639,853
-3,689
| -0.6% | -$39.7K | ﹤0.01% | 2935 |
|
|
2020
Q2 | $6.73M | Buy |
643,542
+162,150
| +34% | +$1.46M | ﹤0.01% | 2952 |
|
|
2020
Q1 | $3.45M | Sell |
481,392
-603
| -0.1% | -$6.26K | ﹤0.01% | 3127 |
|
|
2019
Q4 | $6.46M | Buy |
481,995
+17,728
| +4% | +$253K | ﹤0.01% | 3075 |
|
|
2019
Q3 | $7.17M | Buy |
464,267
+1,073
| +0.2% | +$13.9K | ﹤0.01% | 2996 |
|
|
2019
Q2 | $6.11M | Buy |
463,194
+22,800
| +5% | +$311K | ﹤0.01% | 3097 |
|
|
2019
Q1 | $7.75M | Buy |
440,394
+69,209
| +19% | +$1.09M | ﹤0.01% | 2962 |
|
|
2018
Q4 | $4.25M | Buy |
371,185
+36,278
| +11% | +$439K | ﹤0.01% | 3141 |
|
|
2018
Q3 | $4.75M | Buy |
334,907
+77,157
| +30% | +$1.1M | ﹤0.01% | 3259 |
|
|
2018
Q2 | $3.9M | Buy |
257,750
+26,372
| +11% | +$446K | ﹤0.01% | 3285 |
|
|
2018
Q1 | $3.13M | Buy |
231,378
+6,738
| +3% | +$128K | ﹤0.01% | 3309 |
|
|
2017
Q4 | $5.3M | Sell |
224,640
-34,645
| -13% | -$818K | ﹤0.01% | 3113 |
|
|
2017
Q3 | $4.83M | Sell |
259,285
-8,525
| -3% | -$194K | ﹤0.01% | 3134 |
|
|
2017
Q2 | $9.25M | Buy |
267,810
+88,902
| +50% | +$2.44M | ﹤0.01% | 2817 |
|
|
2017
Q1 | $3.65M | Buy |
178,908
+139,572
| +355% | +$1.9M | ﹤0.01% | 3173 |
|
|
2016
Q4 | $256K | Buy |
+39,336
| New | +$233K | ﹤0.01% | 3851 |
|
Other funds holding PLSE
PCM
GAM
BIG
Vanguard Group's PLSE Position: Q4 2025 in Review
Vanguard Group increased its Pulse Biosciences (PLSE) stake by 0.45% in Q4 2025, buying an estimated $78.7K and bringing the position to 1,118,743 shares worth $15.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2743.
Vanguard Group first reported a position in PLSE in Q4 2016 and has held it in 37 quarters since. The position peaked at $20M in Q4 2024. 82 funds tracked by Wall St. Rank hold PLSE as of Q4 2025.
- Vanguard Group held 1,118,743 shares of Pulse Biosciences worth $15.4M as of Q4 2025.
- Vanguard Group bought 5,052 Pulse Biosciences shares in Q4 2025, an estimated $78.7K.
- Pulse Biosciences made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2743 holding.
- Vanguard Group first reported a position in Pulse Biosciences in Q4 2016 and has held it in 37 quarters since.
- Vanguard Group's Pulse Biosciences position peaked at $20M in Q4 2024.
- 82 funds tracked by Wall St. Rank held Pulse Biosciences as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.